- Home
- MREO vs EOSE Comparison
MREO vs EOSE Comparison
Compare MREO & EOSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- EOSE
- Stock Information
- Founded
- MREO 2015
- EOSE 2008
- Country
- MREO United Kingdom
- EOSE United States
- Employees
- MREO N/A
- EOSE N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- EOSE Industrial Machinery/Components
- Sector
- MREO Health Care
- EOSE Miscellaneous
- Exchange
- MREO Nasdaq
- EOSE Nasdaq
- Market Cap
- MREO 577.6M
- EOSE 542.2M
- IPO Year
- MREO N/A
- EOSE N/A
- Fundamental
- Price
- MREO $3.72
- EOSE $2.70
- Analyst Decision
- MREO Strong Buy
- EOSE Strong Buy
- Analyst Count
- MREO 4
- EOSE 6
- Target Price
- MREO $7.50
- EOSE $5.42
- AVG Volume (30 Days)
- MREO 818.6K
- EOSE 7.8M
- Earning Date
- MREO 11-12-2024
- EOSE 11-05-2024
- Dividend Yield
- MREO N/A
- EOSE N/A
- EPS Growth
- MREO N/A
- EOSE N/A
- EPS
- MREO N/A
- EOSE N/A
- Revenue
- MREO $1,000,000.00
- EOSE $14,963,000.00
- Revenue This Year
- MREO $16.39
- EOSE $187.90
- Revenue Next Year
- MREO $9.44
- EOSE $391.53
- P/E Ratio
- MREO N/A
- EOSE N/A
- Revenue Growth
- MREO N/A
- EOSE 20.34
- 52 Week Low
- MREO $1.86
- EOSE $0.61
- 52 Week High
- MREO $5.02
- EOSE $3.66
- Technical
- Relative Strength Index (RSI)
- MREO 41.37
- EOSE 50.80
- Support Level
- MREO $3.18
- EOSE $2.06
- Resistance Level
- MREO $4.40
- EOSE $2.36
- Average True Range (ATR)
- MREO 0.23
- EOSE 0.24
- MACD
- MREO -0.04
- EOSE -0.01
- Stochastic Oscillator
- MREO 44.67
- EOSE 56.14
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About EOSE Eos Energy Enterprises Inc.
Eos Energy Enterprises Inc designs develop, manufactures, and markets zinc-based energy storage solutions for utility-scale, microgrid, and commercial & industrial (C&I) applications. The solutions are used in the utility sector, the renewable energy sector, and the industrial sector. It's flagship product Eos Znyth is a stationary battery energy storage system.